Amoy Diagnostics Co (SZSE:300685) Interest Expense : ¥-1 Mil (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Amoy Diagnostics Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Amoy Diagnostics Co's interest expense for the three months ended in Mar. 2024 was ¥ -0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Amoy Diagnostics Co's Operating Income for the three months ended in Mar. 2024 was ¥ 68 Mil. Amoy Diagnostics Co's Interest Expense for the three months ended in Mar. 2024 was ¥ -0 Mil. Amoy Diagnostics Co's Interest Coverage for the quarter that ended in Mar. 2024 was 222.99. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Amoy Diagnostics Co Interest Expense Historical Data

The historical data trend for Amoy Diagnostics Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amoy Diagnostics Co Interest Expense Chart

Amoy Diagnostics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.05

-0.86

-0.38

-0.99

-1.20

Amoy Diagnostics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-0.32	-0.33	-0.20	-0.35	-0.31

Amoy Diagnostics Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-1 Mil.

Amoy Diagnostics Co (SZSE:300685) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Amoy Diagnostics Co's Interest Expense for the three months ended in Mar. 2024 was ¥-0 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥68 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥46 Mil.

Amoy Diagnostics Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	68.457	/	-0.307
	=	222.99

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Amoy Diagnostics Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.

Amoy Diagnostics Co (SZSE:300685) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Amoy Diagnostics Co Ltd (SZSE:300685) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

39 Dingshan Road, Haicang District, Xiamen, CHN, 361027

Website

http://www.amoydx.com

Amoy Diagnostics Co Ltd is the pharmaceutical company based in China. The company primarily focuses on molecular diagnostics for oncology precision medicine. It provides diagnostic products and services for medicine development and clinical oncology practice. The company's products include gene mutation, nucleic acid extraction, and molecular diagnostic kits comprising EGFR, RAS, ALK, BRAF, PIK3CA, and ROS1 testing kits.

Executives

Ruan Li	Directors, executives
Zheng Hui Bin	Directors, executives
Chen Ying	Directors, executives
Luo Jie Min	Executives
Zhu Guan Shan	Directors, executives
Yang Shou Qian	Securities Affairs Representative
Zhou Wen Gang	Executives
Zhou Xue Lin	Independent director
Hu Xu Bo	Director

Amoy Diagnostics Co (SZSE:300685) Headlines

No Headlines